Reporting methods of blinding in randomized trials assessing nonpharmacological treatments

被引:247
作者
Boutron, Isabelle [1 ]
Guittet, Lydia
Estellat, Candice
Moher, David
Hrobjartsson, Asbjorn
Ravaud, Philippe
机构
[1] INSERM, U738, Paris, France
[2] Univ Paris 07, UFR Med, Paris, France
[3] Hop Bichat Claude Bernard, AP HP, Dept Epidemiol Biostat & Rech Clin, F-75877 Paris, France
[4] Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada
[5] Univ Ottawa, Fac Med, Dept Epidemiol & Community Med, Ottawa, ON, Canada
[6] Rigshosp, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark
关键词
D O I
10.1371/journal.pmed.0040061
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Blinding is a cornerstone of treatment evaluation. Blinding is more difficult to obtain in trials assessing nonpharmacological treatment and frequently relies on "creative'' (nonstandard) methods. The purpose of this study was to systematically describe the strategies used to obtain blinding in a sample of randomized controlled trials of nonpharmacological treatment. Methods and Findings We systematically searched in Medline and the Cochrane Methodology Register for randomized controlled trials (RCTs) assessing nonpharmacological treatment with blinding, published during 2004 in high-impact-factor journals. Data were extracted using a standardized extraction form. We identified 145 articles, with the method of blinding described in 123 of the reports. Methods of blinding of participants and/or health care providers and/or other caregivers concerned mainly use of sham procedures such as simulation of surgical procedures, similar attention-control interventions, or a placebo with a different mode of administration for rehabilitation or psychotherapy. Trials assessing devices reported various placebo interventions such as use of sham prosthesis, identical apparatus (e. g., identical but inactivated machine or use of activated machine with a barrier to block the treatment), or simulation of using a device. Blinding participants to the study hypothesis was also an important method of blinding. The methods reported for blinding outcome assessors relied mainly on centralized assessment of paraclinical examinations, clinical examinations (i.e., use of video, audiotape, photography), or adjudications of clinical events. Conclusions This study classifies blinding methods and provides a detailed description of methods that could overcome some barriers of blinding in clinical trials assessing nonpharmacological treatment, and provides information for readers assessing the quality of results of such trials.
引用
收藏
页码:370 / 380
页数:11
相关论文
共 57 条
[1]   Turning a blind eye - Testing the success of blinding and the CONSORT statement [J].
Altman, DG ;
Schulz, KF ;
Moher, D .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7448) :1135-1135
[2]   The revised CONSORT statement for reporting randomized trials: Explanation and elaboration [J].
Altman, DG ;
Schulz, KF ;
Moher, D ;
Egger, M ;
Davidoff, F ;
Elbourne, D ;
Gotzsche, PC ;
Lang, T .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) :663-694
[3]  
Baker KR, 2001, J RHEUMATOL, V28, P1655
[4]   A comparison of active and simulated chiropractic manipulation as adjunctive treatment for childhood asthma [J].
Balon, J ;
Aker, PD ;
Crowther, ER ;
Danielson, C ;
Cox, PG ;
O'Shaughnessy, D ;
Walker, C ;
Goldsmith, CH ;
Duku, E ;
Sears, MR .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (15) :1013-1020
[5]   The quality of reporting of randomized trials in The Journal of Bone and Joint Surgery from 1988 through 2000 [J].
Bhandari, M ;
Richards, RR ;
Sprague, S ;
Schemitsch, EH .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2002, 84A (03) :388-396
[6]   Developing a measure of treatment beliefs: The complementary and alternative medicine beliefs inventory [J].
Bishop, FL ;
Yardley, L ;
Lewith, G .
COMPLEMENTARY THERAPIES IN MEDICINE, 2005, 13 (02) :144-149
[7]   Patients' evaluation of informed consent to postponed information: cohort study [J].
Boter, H ;
van Delden, JJM ;
de Haan, RJ ;
Rinkel, GJE .
BRITISH MEDICAL JOURNAL, 2004, 329 (7457) :86-86
[8]   A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus [J].
Boutron, I ;
Moher, D ;
Tugwell, P ;
Giraudeau, B ;
Poiraudeau, S ;
Nizard, R ;
Ravaud, P .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2005, 58 (12) :1233-1240
[9]   A review of blinding in randomized controlled trials found results inconsistent and questionable [J].
Boutron, I ;
Estellat, C ;
Ravaud, P .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2005, 58 (12) :1220-1226
[10]   Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials [J].
Boutron, I ;
Tubach, F ;
Giraudeau, B ;
Ravaud, P .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2004, 57 (06) :543-550